Assessment and management of chronic hepatitis C infection

被引：1

作者：

Brooks, CL

Rosenberg, WM

机构：

[1] Queen Alexandra Hosp, Portsmouth, Hants, England

[2] Univ Southampton, Southampton SO9 5NH, Hants, England

[3] Southampton Univ Hosp Trust, Southampton, Hants, England

来源：

CLINICAL MEDICINE | 2002年 / 2卷 / 04期

关键词：

chronic hepatitis; hepatitis; C virus; interferon; PEGylated interferon; ribavirin; viral hepatitis;

D O I：

10.7861/clinmedicine.2-4-302

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：302 / 306

页数：5

共 13 条

[11] Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus [J].

Poynard, T ;

Marcellin, P ;

Lee, SS ;

Niederau, C ;

Minuk, GS ;

Ideo, G ;

Bain, V ;

Heathcote, J ;

Zeuzem, S ;

Trepo, C ;

Albrecht, J .

LANCET, 1998, 352 (9138) :1426-1432

[12] The role of liver biopsy in chronic hepatitis C [J].

Saadeh, S ;

Cammell, G ;

Carey, WD ;

Younossi, Z ;

Barnes, D ;

Easley, K .

HEPATOLOGY, 2001, 33 (01) :196-200

[13] Peginterferon alfa-2a in patients with chronic hepatitis C [J].

Zeuzem, S ;

Feinman, SV ;

Rasenack, J ;

Heathcote, EJ ;

Lai, MY ;

Gane, E ;

O'Grady, J ;

Reichen, J ;

Diago, M ;

Lin, A ;

Hoffman, J ;

Brunda, MJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (23) :1666-1672

← 1 2 →